![]() |
|
|
![]() |
||
| Tuesday November 17, 2009 NOON | |||||||||||||||||||||||||||||||||||||||||||||||
Samar Basu, Ph.D. |
![]() |
||||||||||||||||||||||||||||||||||||||||||||||
| Title: | "Eicosanoids- An evidenced link to oxidative stress and inflammation" |
||||||||||||||||||||||||||||||||||||||||||||||
| Date: | Tuesday November 17, 2009 | ||||||||||||||||||||||||||||||||||||||||||||||
| Location: | VCOM Board Room | ||||||||||||||||||||||||||||||||||||||||||||||
| Time: | 12:00 NOON | ||||||||||||||||||||||||||||||||||||||||||||||
| Contact: | Samar Basu, Ph.D. |
||||||||||||||||||||||||||||||||||||||||||||||
Professional Summary:Samar Basu is an Associate Professor and Head of the Research Group, Oxidative Stress and Inflammation at the Medical Faculty, Uppsala University, Sweden, and also a Visiting Scientist at the Harvard Medical School, Boston. He obtained his M.Sc. (Reproductive Endocrinilogy, 1984) and Ph.D. (Reproductive Endocrinology/Obstetric and Gynaecology, 1988) from the Veterinary Medical Faculty in Uppsala under supervision of Prof. Hans Kindahl who is a decendent from Prof. Bengt Samuelsson’s prostaglandin laboratory at the Karolinska Institute, Stockholm where the prostaglandins were discovered. Following his Ph.D. in prostaglandins in pregnancy he joined Pharmacia as a Scientist for drug development against Glaucoma. He had a key role as Study Director and main author on the studies on pharmacokinetics, metabolism, toxicokinetics and detection of Latanoprost/Xalatan and other prostaglandin analogues. XalatanR, a potent prostaglandin-based drug against Glaucoma registered world-wide in 1996 and sells over 1 billion US $ per year. After that he joined Uppsala University in 1996 where he devoted to research on Oxidative stress and inflammation in various diseases, specifically on isoprostanes and prostaglandins and their regulation. Abstract:Oxidative Stress and Inflammation, Department of Public Health. Faculty of Medicine, Uppsala University, Uppsala Science Park, SE-751 85 Uppsala, Sweden (samar.basu@pubcare.uu.se) Arachidonic acid oxidation through free radicals and by cyclooxygenaes results in several short-lived unique bioactive compounds in the mammalian body namely, prostaglandins (PG) and isoprostanes. These eicosanoids are reliable parameters of oxidative stress and inflammation in addition to their vasoconstrictive, inflammatory and platelet-aggrigatory properties. Prostaglandin F2alpha (PGF2alpha) is a potent vasoconstrictory compound and is involved in various acute and chronic inflammation. 8-Iso-PGF2alpha, a major F2 -isoprostane evokes vasoconstriction in lung and kidney, and also serves as a reliable indicator of oxidative stress. By raising highly specific antibodies against 8-iso-PGF2alpha and PGF2alpha metabolite, we have investigated tissue injury and also their role in vivo. These methods have been successfully applied for studies of oxidative stress and inflammation and also drugs/antioxidants/radical scavengers treatment studies, namely experimental septic shock and acute inflammation, cardiopulmonary resuscitation (CPR) and brain injury after cardiac arrest, asthma, bone mineral density, cardiopulmonary bypass (CPB), pecutaneous coronary intervention (PCI) and angiography and several rheumatic diseases and risk factors of atherosclerosis. Rapid increase of these bioactive eicosanoids in experimental septic shock, CPR, CPB, PCI/angiography, and a higher levels of these parameters in patients with type 1 and type 2 diabetes, obesity, asthma, rheumatic diseases and smokers have seen in the body fluids with a distinct kinetics of appearance and disappearance, in addition to their regulation by various drugs and antioxidants. Thus, both isoprostanes and prostaglandins are involved in various diseases and riskfactors for atherosclerosis, and are potent target compounds to study oxidative stress and inflammation. In addition, these compounds have profound activities in physiology, like pregnancy which increases their novelty. |
|||||||||||||||||||||||||||||||||||||||||||||||
| Monday May 18. 2009 NOON | |||||||||||||||||||||||||||||||||||||||||||||||
Young H. Ju, Ph.D. |
![]() |
||||||||||||||||||||||||||||||||||||||||||||||
| Title: | "Soy isoflavones and breast cancer" | ||||||||||||||||||||||||||||||||||||||||||||||
| Date: | Monday May 18, 2009 | ||||||||||||||||||||||||||||||||||||||||||||||
| Location: | CME Room 3rd Floor VCOM | ||||||||||||||||||||||||||||||||||||||||||||||
| Time: | 12:00 NOON | ||||||||||||||||||||||||||||||||||||||||||||||
| Contact: | Young H. Ju, Ph.D. |
||||||||||||||||||||||||||||||||||||||||||||||
Professional Summary:In August, 2004, I have started my career as a tenure-track faculty in the Department of Human Nutrition, Foods and Exercise at Virginia Tech. My major research interests are to identify bioactive food components that modify the breast cancer initiation and development, maximize efficacy and minimize adverse effects of dietary compounds, and understand their underlying molecular mechanisms of action on breast cancer. Abstract:After menopause, reductions in the ovarian production and circulating levels of estrogen cause many women to experience symptoms such as hot flashes and mood swings. Hormone replacement therapy (HRT) is often prescribed to relieve these symptoms. However, many women are choosing not to use HRT because of recent reports warning against possible detrimental effects of conventional HRT on estrogen-regulated diseases including breast cancer, ovarian cancer, heart disease, and dementia. Estrogens derived from plants (isoflavones) have been promoted as natural alternatives to conventional HRT, and a dramatic increase in the consumption of isoflavone supplements and products enriched with isoflavones has been documented in postmenopausal women. The sales of soy and soy components are approaching 4 billion dollars annually, and the levels of estrogenic dietary isoflavones consumed by older Americans are increasing dramatically, due to active marketing of their perceived and potential health benefits. We have investigated effect of a soy isoflavone, genistein, on breast cancer development, and their interaction with prescription drugs used to treat breast cancer using pre-clinical breast cancer models. We have found detrimental effects of genistein; genistein at physiological concentrations stimulates the growth of estrogen receptor (ER) positive human breast cancer cells in vitro and in vivo; genistein negates the inhibitory effects of tamoxifen (an ER antagonist) and letrozole (an aromatase inhibitor) on the growth of ER(+) human breast cancer cells in vitro and in vivo; long-term dietary genistein exposure accelerates the progression of estrogen- and antiestrogen-responsive breast tumors to estrogen-insensitive breast tumors; and genistein-induced estrogen-insensitive tumors are able to grow aggressively without genistein supplementation. Results from these studies raise concerns about the consumption of genistein-containing products by postmenopausal women with breast cancer. Education:
Positions and Honors:
Selected peer-reviewed publications (in chronological order):
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Thursday February 5, 2009 NOON | |||||||||||||||||||||||||||||||||||||||||||||||
Heather F. Smith, Ph.D. |
![]() |
||||||||||||||||||||||||||||||||||||||||||||||
| Title: | "Evolution and phylogenetic patterning of 3D morphological variation in the primate cranium" | ||||||||||||||||||||||||||||||||||||||||||||||
| Date: | Thursday, February 5, 2009 | ||||||||||||||||||||||||||||||||||||||||||||||
| Location: | Mr. Rocovich’s Conference Room, 3rd Floor VCOM | ||||||||||||||||||||||||||||||||||||||||||||||
| Time: | 12:00 Noon | ||||||||||||||||||||||||||||||||||||||||||||||
| Contact: | Heather F. Smith, Ph.D. |
||||||||||||||||||||||||||||||||||||||||||||||
Abstract:As different functional and developmental modules (FDMs) of the skull in humans and other primates experience different loading regimes, patterns of ossification, and ontogenetic trajectories, it is likely that they will reflect phylogenetic information differentially and evolve according to different processes. The three-dimensional morphology of crania from a wide range of geographically dispersed populations were compared to molecular data and environmental variables to determine which FDMs are most informative about population history in humans. It was determined that the endochondrally ossifying basicranium and temporal bone reflected genetic distance most reliably, followed by the upper facial skeleton, dentition, and mandible. The morphology of the neurocranium, and the high strain masticatory regions of the facial skeleton, however, exhibited extensive plasticity. An investigation of climatic variables revealed a correlation between cranial size and mean annual temperature, and that temporal bone shape is evolving under an isolation by distance model. An investigation using papionin (baboon) primates found that their cranial morphology is characterized by allometry, or size-related shape changes. Finally, a comparison of temporal bone morphology in Neandertals, Anatomically Modern Humans, and modern human populations indicated a distant relationship between Neandertals and modern humans, supporting an Out of Africa model for modern human origins. Education:
Positions and Honors:
Selected peer-reviewed publications (in chronological order):
Research Projects Ongoing or Completed During the Last 3 Years:
Teaching Experience:Classes co-taught as post-doctoral associate
Graduate teaching assistant positions
Summary:Dr. Heather Smith is a postdoctoral research associate in the College of Medicine at the University of Arizona. Her current postdoctoral research projects include an investigation of paraspinal muscular defects in Notch signaling pathway mutant mice, and a comparative anatomical study of the mammalian cecal appendix. Her independent research, starting with her Ph.D. dissertation, has focused on the genetic and epigenetic factors contributing to differences in cranial morphology across primates, and the evolution of current patterns of cranial variation. In addition to conducting her research, Dr. Smith currently co-teaches a dissection-based gross anatomy course for first-year medical students at the University of Arizona. Dr. Smith completed a Bachelors’ degree in Biological Anthropology at Arizona State University’s Barrett Honors College in 2001, and a Masters’ degree in Biological Anthropology from Stony Brook University in 2003. She returned to Arizona State to complete her Ph.D. in Biological Anthropology, which she was awarded in May 2008. Her dissertation research on human cranial morphology and evolution was supported by grants from the National Science Foundation and the Wenner-Gren Foundation for Anthropological Research. |
|||||||||||||||||||||||||||||||||||||||||||||||
| Monday January 19, 2009 NOON | |||||||||||||||||||||||||||||||||||||||||||||||
John A. Anstrom, Ph. D. |
![]() |
||||||||||||||||||||||||||||||||||||||||||||||
| Title: | "Histological Development of Cerebral Vessels in Human Neonates Born Prematurely: Relation to Germinal Matrix Hemorrhage" |
||||||||||||||||||||||||||||||||||||||||||||||
| Date: | Monday January 19, 2009 | ||||||||||||||||||||||||||||||||||||||||||||||
| Location: | VCOM Board Room, 3rd Floor VCOM | ||||||||||||||||||||||||||||||||||||||||||||||
| Time: | 12:00 NOON | ||||||||||||||||||||||||||||||||||||||||||||||
| Contact: | John A. Anstrom, Ph. D. |
||||||||||||||||||||||||||||||||||||||||||||||
Abstract:Approximately 10% of all births in the US are premature. Neonates born prematurely are at risk for hemorrhage in the germinal matrix, a collection of neuronal precursor cells present in the subventricular zone of the brain until 38 weeks gestation. The etiology of germinal matrix hemorrhage is complex and involves blood flow dynamics, factors intrinsic to the blood vessel wall, as well as factors extrinsic to the wall such as the association between brain vessels and glial end-feet. We have carried out autopsy studies using brain from neonates born live during the third trimester and died within the first few hours or days following birth to assess the developmental status of brain vessels. Using immunohistochemistry, structural components in the wall of germinal matrix vessels were compared to similarly prepared vessels in other brain regions where hemorrhage is not frequent. Capillaries in the germinal matrix exhibit an accumulation of collagen IV, a major structural protein of the basement membrane, equivalent to that displayed by vessels in other brain areas indicating that the vessel wall does not lack in this extracellular component and therefore, hemorrhage is not related to an absence of intrinsic structural support. Germinal matrix vessels do however, exhibit differences in the accumulation of blood-brain barrier components when compared to vessels in other brain regions. We hypothesize that endothelial cells of germinal matrix vessels are slow to accumulate the proteins of tight junctions that are the structural basis of the blood-brain barrier. An incomplete and weak connection between adjacent endothelial cells, related to a paucity of tight junction proteins, may leave these vessels particularly susceptible to the underlying systemic factors that lead to vascular rupture. Education:
Professional Experience:
Teaching Experience:
Research Experience:Interests:Cell biological nature of embryogenesis: I have used sea urchin embryos to study the transformation of embryonic epithelial cells into migratory mesenchymal cells. Cerebral vascular development and pathology: I have studied the anatomical maturation of cerebral blood vessels in human neonates at ages corresponding to the third trimester and have related the results to germinal matrix hemorrhage—a significant medical problem that afflicts babies born prematurely. Grant History:Intramural Research Support March of Dimes Birth Defects Foundation (Basil O'Connor Starter Scholar Research Award); 10/1/1988 - 9/31/1991; $75,000 Selected Recent Publications:
Professional Summary:I received my BS degree in Biology from the Pennsylvania State University and PhD degree in Anatomical Sciences from the State University of New York at Buffalo. I went on to Indiana University where I worked in the laboratory of Dr. Rudolf Raff, a developmental biologist. My work in Dr. Raff’s lab contributed to the discovery of histone messenger RNAs that are stored exclusively in the pronucleus of an unfertilized oocyte until their release at fertilization. I also used immuno-electron microscopy to describe the distribution of a cell surface glycoprotein that appears on mesenchymal cell precursors of the larval skeleton. Following my move from Indiana University to Wake Forest University School of Medicine (known at the time as The Bowman Gray School of Medicine) I continued my microscopic studies of sea urchin embryonic mesenchymal cells, using this system as a means to understand epithelial-mesenchymal transformations as they occur in most embryos including humans. In 1998 I changed my emphasis and began to apply my microscopic methods to the development of cerebral blood vessels in the human brain. This work was in collaboration with Dr. Dixon Moody of the Department of Radiology at Wake Forest University School of Medicine. Several of our articles described structural aspects of vessels in the subventricular area of the brain of neonates born prematurely and have assessed how vessel wall structure might influence the development of hemorrhage in this special population of newborns.
|
|||||||||||||||||||||||||||||||||||||||||||||||